Catalog No.
Product Name
Application
Product Information
Citations
-
Tobramycin Impurity
Deoxystreptamine kanosaminide is an impurity of Tobramycin, classified as an aminoglycoside antibiotic. This compound is important for analytical studies and quality control in the production of Tobramycin, offering insights into its chemical stability and purity. It serves as a reference standard in research focused on aminoglycoside-related pharmacology and antibiotic efficacy. -
Drug Impurity
Haloperidol impurity 5, identified as Haloperidol impurity F, is a known impurity associated with the antipsychotic drug Haloperidol. It is crucial for studies focused on drug characterization and quality assessment in pharmaceutical formulations. This impurity can be utilized in research to evaluate the stability and safety profiles of Haloperidol and its derivatives, contributing to the understanding of drug metabolism and potential side effects. -
Drug Impurity
Glipizide impurity 6 is a chemical impurity associated with the antidiabetic agent Glipizide. It is used primarily in quality control to ensure the purity and safety of pharmaceutical formulations containing Glipizide. This impurity can also aid in the identification and quantification of Glipizide-related compounds in research and development settings. -
Drug Impurity
Tramadol impurity 1 is a minor impurity associated with the synthesis of Tramadol, an opioid analgesic. This compound is essential for analytical studies and quality control in pharmaceutical research. Its characterization and quantification are important for ensuring the purity of Tramadol formulations and adhering to regulatory standards. -
Drug Impurity
Betamethasone impurity 7 is a drug impurity associated with betamethasone, a corticosteroid with anti-inflammatory properties. This impurity can serve as an important quality control marker during the synthesis and analysis of betamethasone formulations. Its characterization is essential for ensuring the purity and compliance of pharmaceutical products in drug development and regulatory environments. -
Drug Impurity
Rivaroxaban impurity 34 is a chemical impurity associated with Rivaroxaban, an oral anticoagulant that inhibits Factor Xa. This impurity serves as a key reference standard in analytical and quality control settings to assess the purity and quality of Rivaroxaban formulations. It is essential for research applications focusing on drug stability, formulation development, and regulatory compliance in the pharmaceutical industry. -
Drug Impurity
Fluphenazine decanoate impurity 9 is a chemical impurity associated with Fluphenazine decanoate. It serves as a critical reference standard for analytical and quality control purposes in pharmaceutical research. This impurity can aid in understanding the drug's stability, purity, and safety profile, and is useful in the development and validation of analytical methods. Researchers focusing on drug formulation and regulatory compliance will find this compound essential for investigating the characteristics of Fluphenazine decanoate. -
Drug Impurity
Perindopril impurity 1 is a chemically related impurity of the cardiovascular agent Perindopril, which primarily targets angiotensin-converting enzyme (ACE). This compound serves as a reference standard in pharmaceutical research and development, particularly for the quality control and characterization of Perindopril formulations. It is critical for ensuring compliance with regulatory standards and for evaluating the stability and purity of related drug products. -
Drug Intermediate
2-Acetyldibenzofuran is a dibenzofuran derivative utilized as a drug intermediate. It plays a crucial role in the synthesis of photosensitizers, which are important in photodynamic therapy and other applications requiring light-sensitive compounds. Its utility in organic synthesis makes it valuable for research in medicinal chemistry and related fields. -
Triamcinolone acetonide Impurity
Δ14-Triamcinolone acetonide is a potential impurity of triamcinolone acetonide, a potent glucocorticoid. It has been shown to inhibit the proliferation of retinal endothelial cells induced by basic fibroblast growth factor (bFGF). Additionally, it reduces chondrocyte viability, contributing to cartilage destruction. This compound is applicable in research related to inflammatory conditions, including atopic dermatitis. -
Drug Impurity
Ethambutol impurity 1 is a known impurity of the anti-tubercular agent Ethambutol, primarily assessed for its chemical structure and properties. It serves as a crucial substance in studies evaluating the purity of Ethambutol formulations and understanding the potential effects of impurities on drug efficacy and safety. This reagent is essential for pharmaceutical quality control and can be used in research focused on developing new therapeutic strategies against tuberculosis. -
Drug Impurity
Raloxifene impurity 8 is a notable impurity associated with the selective estrogen receptor modulator, Raloxifene. The presence of this impurity may influence pharmacological activity and stability in formulations. It serves as an important reference standard for quality control and analytical studies in pharmaceutical research related to women's health and osteoporosis treatment. -
Drug Intermediate Control
Benzyl (1R,3R)-3-hydroxycyclopentane-1-carboxylate serves as a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound is crucial for the development of various bioactive molecules with potential therapeutic applications. Its role as an intermediate enables the structural modification of lead compounds, facilitating the discovery of novel drugs targeting diverse biological pathways. -
Drug Impurity
Amiodarone impurity 1, also known as Amiodarone N-oxide, is a characterized impurity derived from the antiarrhythmic agent Amiodarone. It is important for research applications related to drug formulation and quality control, as well as studies investigating the metabolism and pharmacokinetics of Amiodarone. Analysis of such impurities can help enhance the understanding of potential side effects and therapeutic efficacy. -
Drug Impurity
Apremilast impurity 2 is a chemical impurity associated with Apremilast, a phosphodiesterase 4 (PDE4) inhibitor. This compound is utilized in research to assess the purity and stability of pharmaceutical formulations containing Apremilast. Its characterization can assist in understanding potential impacts on drug efficacy and safety profiles in therapeutic applications. -
Drug Impurity
Glipizide impurity 13 is a recognized impurity associated with Glipizide, an antidiabetic medication. This compound serves as a critical reference standard for the analysis and quality control of Glipizide formulations. Its identification and quantification are essential for ensuring the purity and safety of pharmaceutical products containing Glipizide, contributing to regulatory compliance in drug development and manufacturing. -
Drug Impurity
Estradiol impurity 7, also known as delta9,11-Estradiol, is a known impurity associated with Estradiol. This compound is primarily studied for its potential impacts on hormonal assays and the evaluation of pharmaceutical purity. Its presence may influence the biological activity of formulations containing Estradiol, making it relevant for quality control in drug development and analysis. -
Drug Impurity
Bupropion impurity 14 is a chemical impurity associated with Bupropion, a widely used antidepressant and smoking cessation aid. Characterized as a byproduct in the synthesis of Bupropion, this compound serves as an essential reference standard in pharmaceutical analysis and quality control. It is crucial for ensuring the safety and efficacy of Bupropion formulations in both research and clinical settings. -
Drug Impurity
Glycopyrrolate impurity 1 bromide is a known impurity of Glycopyrrolate bromide, primarily categorized as a drug impurity. It is utilized in chemical research to assess the purity and quality of Glycopyrrolate formulations. Its presence is crucial for regulatory compliance and in analytical studies aimed at understanding the pharmacological profile and safety of Glycopyrrolate-related compounds. -
Drug Impurity
Ranolazine impurity 9 is a byproduct of Ranolazine synthesis, serving as a chemical marker for purity assessment in pharmaceutical research. Its characterization is crucial for quality control in drug development, particularly in the evaluation of Ranolazine formulations. This impurity can aid in understanding the overall safety and efficacy profiles of the primary compound in clinical applications. -
Drug Impurity
4-Chloro Trazodone is a known drug impurity with a primary mechanism of action linked to serotonergic modulation. It is relevant in the study of the pharmacological profiles of trazodone and its metabolites. This compound is utilized in analytical chemistry and quality control processes to evaluate the presence and concentration of impurities in pharmaceutical formulations. -
Drug Impurity
Metoprolol impurity 2 hydrochloride is a secondary metabolite related to Metoprolol hydrochloride, functioning primarily as a drug impurity. Its presence is important for analytical research in pharmaceutical development, aiding in the evaluation of drug purity and stability. This compound serves as a reference material for quality control and regulatory compliance in drug manufacturing processes. -
Drug Impurity
Rivaroxaban impurity 24 is a known impurity associated with Rivaroxaban, an oral anticoagulant that inhibits Factor Xa, thereby blocking the conversion of prothrombin to thrombin. Understanding this impurity is essential for quality control and assurance in the production of Rivaroxaban. This compound serves as an important reference standard for the analysis of drug purity and stability, making it valuable for pharmaceutical research and development applications. -
Drug Impurity
Azithromycin impurity 2 is a known impurity associated with the antibiotic Azithromycin. It serves as an important reference standard for analytical and quality control applications in pharmaceutical research. The characterization and quantification of this impurity can aid in the assessment of drug purity and efficacy, contributing to the development of safer and more effective antibiotic formulations. -
Drug Impurity
Azilsartan impurity 24, also known as O-Desethyl azilsartan, is a drug impurity associated with Azilsartan. Its presence in formulations is important for quality control and regulatory compliance in pharmaceutical development. Researchers may utilize this compound to assess the purity of Azilsartan and to investigate its potential effects on biological activity. -
Drug Intermediate
(1-Benzylpiperidin-3-yl)methanol is a chemical intermediate primarily used in the synthesis of pharmaceutical compounds. This compound facilitates research into Alzheimer's disease by serving as a precursor for biologically active molecules. Its applications extend to the development of potential therapeutic agents aimed at understanding and treating neurodegenerative disorders. -
Drug Impurity
Celecoxib impurity 1 is a chemical impurity associated with the synthesis of Celecoxib. Its presence can impact the purity and efficacy of pharmaceutical formulations. This impurity serves as a critical reference standard for quality control and analytical processes in drug development, ensuring compliance with regulatory requirements and improving the safety profile of Celecoxib-containing products. -
Drug Impurity
Apixaban impurity 52 is a characterized impurity of the anticoagulant Apixaban. This compound serves as a critical reference standard for researchers assessing the purity and quality of Apixaban in pharmaceutical formulations. Its analysis is essential for ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Allopurinol impurity 3 is a chemical impurity associated with allopurinol, a medication primarily used for the management of gout and hyperuricemia. This impurity is relevant for analytical studies, quality control processes, and the regulatory assessment of allopurinol formulations. Understanding and characterizing such impurities is essential for ensuring the safety and efficacy of pharmaceutical products. -
Drug Impurity
Acyclovir impurity 2, also known as O-[(Guanin-7-yl)methyl] acyclovir, serves as a drug impurity associated with Acyclovir. This compound is relevant for quality control and analytical studies involving Acyclovir formulations. Its characterization is essential for ensuring the purity and compliance of pharmaceutical products during drug development and manufacturing processes. -
Drug Impurity
Methylprednisolone impurity 8 is identified as a chemical impurity associated with Methylprednisolone. This impurity may be relevant in pharmaceutical research and quality control, particularly in assessing the purity and stability of Methylprednisolone formulations. Its characterization can support the development of reliable methods for purity analysis and compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Pregnenolone impurity 1 is a chemical impurity associated with Pregnenolone. Its presence is significant for quality control in the synthesis of Pregnenolone-based compounds. This reagent is useful in research focused on the characterization and quantification of drug impurities, ensuring the integrity and safety of pharmacological products. -
Drug Impurity
Ranitidine impurity 1, also known as N-Methylnitroacetamide, is a chemical impurity associated with the drug Ranitidine. This compound is important for studies focused on drug quality and safety, as it provides insights into the stability and degradation products of pharmaceutical formulations. Its analysis aids in ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Imatinib impurity 12 is a known impurity associated with the tyrosine kinase inhibitor Imatinib. Its primary relevance lies in the quality control and characterization of Imatinib formulations. This compound is essential for assessing purity levels and understanding the metabolic pathways during drug development and pharmacokinetic studies. Additionally, it serves as a critical reference for analytical chemists in regulatory compliance and validation processes. -
Drug Impurity
Rivaroxaban impurity 16 is a known impurity of the anticoagulant Rivaroxaban, which functions as a selective inhibitor of Factor Xa. This compound is essential for analytical and quality control studies in the pharmaceutical industry, particularly for assessing the purity and safety of Rivaroxaban formulations. Its role in research allows for a better understanding of drug metabolism and the identification of potential impacts on efficacy and toxicity. -
Drug Impurity
Clarithromycin impurity 11, also known as N-Desmethyl Clarithromycin (9E)-Oxime, is a known impurity associated with the antibiotic Clarithromycin. This compound is essential for analytical and regulatory purposes, aiding in the assessment of drug purity and stability. It is particularly relevant for quality control in pharmaceutical research and development, contributing to the understanding of the compound's metabolic pathways and potential side effects. -
Drug Impurity
Ranitidine impurity 4 is a known impurity of the gastric acid secretion inhibitor Ranitidine. This compound is primarily utilized in pharmaceutical research to assess the purity of Ranitidine formulations and evaluate the stability profiles of related drug products. Its presence can impact the safety and efficacy of the final pharmaceutical formulations, making it essential for quality control and regulatory compliance in drug development. -
Drug Impurity
Ranitidine impurity 13 is identified as an impurity associated with the antihistamine Ranitidine. This compound is critical for quality control and analytical studies in pharmaceutical research, ensuring the integrity and safety of Ranitidine formulations. It serves as a reference standard for assessing the purity and composition of Ranitidine products in compliance with regulatory guidelines. -
Drug Impurity
Prasugrel impurity 7 is a chemical impurity associated with the synthesis of Prasugrel, an antiplatelet medication targeting the P2Y12 receptor. This impurity is critical for quality control and analytical research in pharmaceutical development, enabling the assessment of product purity and safety. Researchers can utilize this reagent to study the effects of impurities on drug efficacy and metabolism, thus contributing to the overall understanding of pharmacological profiles and compliance with regulatory standards. -
Drug Impurity
Levofloxacin impurity 14 is a recognized impurity of the fluoroquinolone antibiotic levofloxacin. As a drug impurity, it plays a critical role in the assessment of the purity and quality of levofloxacin in pharmaceutical formulations. Researchers utilize this compound to conduct stability studies and analytical methods, ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Telmisartan impurity 10 is a drug impurity associated with Telmisartan, an angiotensin II receptor blocker. This compound serves as a valuable reference standard for the assessment of Telmisartan quality and purity in pharmaceutical formulations. It is essential for analytical research and quality control applications to ensure compliance with regulatory standards. -
Drug Intermediate
N-Demethy EM-163 is a key intermediate in the synthesis of the compound EM-163. This reagent facilitates the production of EM-163, which is recognized for its potential therapeutic applications. Researchers utilize N-Demethy EM-163 in drug development processes, particularly in studying the pharmacological effects of EM-163 and its related derivatives. -
Drug Impurity
Azithromycin impurity 14, also known as N'-(Desmethyl)azithromycin, serves as an impurity associated with the antibiotic azithromycin. This compound is significant for analytical chemistry and quality control in pharmaceutical research, aiding in the assessment of drug purity and stability. Its characterization is essential for understanding the potential effects of impurities on drug efficacy and safety. -
Drug Intermediate
2,2,6-Trimethylcyclohexanone, a versatile drug intermediate, plays a crucial role in the synthesis of β-ionone, an important compound in fragrance and flavor industries. Its structural properties make it an essential building block for various synthetic routes in organic chemistry. Researchers utilize this compound in the development of bioactive molecules and in the study of related chemical transformations. -
Drug Impurity
Empagliflozin impurity 15 is an impurity of Empagliflozin, a selective inhibitor of sodium-glucose co-transporter 2 (SGLT2). This compound is utilized primarily for analytical research to assess the purity and stability of Empagliflozin formulations. Its characterization contributes to the understanding of impurities in drug development and ensures quality control in pharmaceutical applications. -
Drug Impurity
Quetiapine impurity 1 is a known impurity related to the antipsychotic medication Quetiapine. This compound serves as an important reference standard for analytical studies and quality control processes in pharmaceutical research. Understanding and identifying impurities like Quetiapine impurity 1 is crucial for ensuring drug safety, efficacy, and compliance with regulatory standards. -
Drug Impurity
Sildenafil impurity 14 is a known impurity of Sildenafil, primarily analyzed in pharmacokinetic and drug stability studies. Its identification and characterization are essential in ensuring the purity and quality of Sildenafil products. This impurity serves as a valuable reference standard for analytical methods such as HPLC and mass spectrometry, enhancing the understanding of impurities in pharmaceutical formulations. -
Drug Impurity
Lincomycin impurity 42 hydrochloride is a chemical structure related to Lincomycin hydrochloride, identified as a drug impurity. This compound is utilized in analytical research to assess the purity and quality of Lincomycin hydrochloride in pharmaceutical formulations. Its detection and quantification can provide essential insights into the manufacturing process and compliance with regulatory standards in the pharmaceutical industry. -
Drug Impurity
Ranolazine impurity 4, also known as Ranolazine impurity B, is a chemical byproduct associated with the synthesis of the antianginal agent ranolazine. This impurity can be utilized in analytical chemistry for the characterization of ranolazine and in the evaluation of purity during formulation development. Its study aids in understanding the safety and efficacy of ranolazine formulations in pharmaceutical research. -
Drug Impurity
Amlodipine Impurity 1 is a synthesized impurity associated with Amlodipine, a calcium channel blocker. It is utilized primarily in drug analysis and quality control to ensure the purity and safety of pharmaceutical formulations. This compound can serve as a reference standard in research and development, aiding in the identification and quantification of impurities in Amlodipine products.
